biotech
biotech Articles
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
In an incredible move for adolescent patients 12 to 17 years of age, the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for with moderate-to-severe atopic dermatitis.
Published:
Last Updated:
Tonix Pharma shares made a solid gain on Monday after the firm announced that it is beginning to enroll patients in its late-stage study of Tonmya for the treatment of post-traumatic stress disorder.
Published:
Last Updated:
Axovant Sciences has produced results from two separate studies related to neurodegenerative diseases, and its shares had a sharp gain to start off the week.
Published:
Last Updated:
Tonix Pharma shares spiked on Friday after the firm announced that it received a patent from the European Patent Office for its “Method for Treating Neurodegenerative Dysfunction.”
Published:
Last Updated:
Bio-Path shares are on a rampage, with its second day of more than doubling. Shares actually were halted at multiple points during the day for volatility spikes. This is all coming after the firm...
Published:
Last Updated:
Bio-Path shares made an incredible run on Wednesday after the company announced interim results from its mid-stage leukemia trial.
Published:
Last Updated:
Intercept Pharmaceuticals was last seen trading higher after the company's financial reporting. While numbers are always important to see, a more subjective issue is a positive review from Wall...
Published:
Last Updated:
Ascendis Pharma shares spiked early Monday as the result of positive top-line results from its late-stage growth hormone study in children.
Published:
Last Updated:
Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The transaction is expected to close by mid-year 2019.
Published:
Last Updated:
Abstracts have been released for the companies presenting at the American Association for Cancer Research annual meeting, and Wedbush has some ideas for what the big movers could be.
Published:
Last Updated:
Lexicon shares jumped on Friday after the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion on the Marketing Authorization of Zynquista...
Published:
Last Updated:
ImmunoGen shares were halved on Friday after the firm reported late-stage results from its ovarian cancer study.
Published:
Last Updated:
Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...
Published:
Last Updated: